FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-231 | 70004-231-22 | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-638 | 70004-638-09 | Glycopyrrolate | .2 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-638 | 70004-638-06 | Glycopyrrolate | .2 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-655 | 70004-655-44 | Heparin Sodium | 2500 [USP'U] | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-652 | 70004-652-46 | Heparin Sodium | 10000 [USP'U] | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-650 | 70004-650-46 | Heparin Sodium | 5000 [USP'U] | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-650 | 70004-650-44 | Heparin Sodium | 5000 [USP'U] | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-664 | 70004-664-46 | Heparin Sodium | 7500 [USP'U] | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-300 | 70004-300-18 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-300 | 70004-300-62 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-302 | 70004-302-22 | Hydromorphone Hydrochloride | .5 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-303 | 70004-303-17 | Hydromorphone Hydrochloride | 1 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-303 | 70004-303-16 | Hydromorphone Hydrochloride | 1 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-303 | 70004-303-22 | Hydromorphone Hydrochloride | 1 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-300 | 70004-300-21 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-300 | 70004-300-16 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-300 | 70004-300-22 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-300 | 70004-300-63 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-303 | 70004-303-21 | Hydromorphone Hydrochloride | 1 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-433 | 70004-433-05 | Ketamine Hydrochloride | 50 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-430 | 70004-430-12 | Ketamine Hydrochloride | 10 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-430 | 70004-430-09 | Ketamine Hydrochloride | 10 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-040 | 70004-040-06 | Atropine Sulfate | .4 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-040 | 70004-040-07 | Atropine Sulfate | .4 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-700 | 70004-700-28 | Labetalol Hydrochloride | 5 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-700 | 70004-700-06 | Labetalol Hydrochloride | 5 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-720 | 70004-720-05 | Lidocaine Hydrochloride | 10 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-720 | 70004-720-12 | Lidocaine Hydrochloride | 10 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-723 | 70004-723-09 | Lidocaine Hydrochloride | 20 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-720 | 70004-720-09 | Lidocaine Hydrochloride | 10 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-728 | 70004-728-12 | Lidocaine Hydrochloride | 20 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-725 | 70004-725-09 | Lidocaine Hydrochloride Anhydrous | 10 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-725 | 70004-725-12 | Lidocaine Hydrochloride Anhydrous | 10 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-725 | 70004-725-05 | Lidocaine Hydrochloride Anhydrous | 10 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-731 | 70004-731-30 | Magnesium Sulfate Heptahydrate | 2 g | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-411 | 70004-411-59 | Midazolam Hydrochloride | 1 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-411 | 70004-411-56 | Midazolam Hydrochloride | 1 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-102 | 70004-102-16 | Morphine Sulfate | 2 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-103 | 70004-103-21 | Morphine Sulfate | 5 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-103 | 70004-103-16 | Morphine Sulfate | 5 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-100 | 70004-100-63 | Morphine Sulfate | 1 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-100 | 70004-100-25 | Morphine Sulfate | 1 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-100 | 70004-100-62 | Morphine Sulfate | 1 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-100 | 70004-100-18 | Morphine Sulfate | 1 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-100 | 70004-100-16 | Morphine Sulfate | 1 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-100 | 70004-100-22 | Morphine Sulfate | 1 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-750 | 70004-750-25 | Neostigmine Methylsulfate | 1 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-750 | 70004-750-09 | Neostigmine Methylsulfate | 1 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-771 | 70004-771-40 | Norepinephrine Bitartrate | .016 mg/1 mL | 2019-1 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-771 | 70004-771-44 | Norepinephrine Bitartrate | .016 mg/1 mL | 2019-1 | valid | 2026-11-14 |